BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 33194742)

  • 1. Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor Suppressor.
    Mal R; Magner A; David J; Datta J; Vallabhaneni M; Kassem M; Manouchehri J; Willingham N; Stover D; Vandeusen J; Sardesai S; Williams N; Wesolowski R; Lustberg M; Ganju RK; Ramaswamy B; Cherian MA
    Front Oncol; 2020; 10():587386. PubMed ID: 33194742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer.
    Datta J; Willingham N; Manouchehri JM; Schnell P; Sheth M; David JJ; Kassem M; Wilson TA; Radomska HS; Coss CC; Bennett CE; Ganju RK; Sardesai SD; Lustberg M; Ramaswamy B; Stover DG; Cherian MA
    Front Oncol; 2022; 12():857590. PubMed ID: 35574319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.
    Campbell-Thompson M; Lynch IJ; Bhardwaj B
    Cancer Res; 2001 Jan; 61(2):632-40. PubMed ID: 11212261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
    Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
    J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective expression of estrogen receptor alpha and beta isoforms in human pituitary tumors.
    Shupnik MA; Pitt LK; Soh AY; Anderson A; Lopes MB; Laws ER
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3965-72. PubMed ID: 9814476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens.
    Hall JM; McDonnell DP
    Endocrinology; 1999 Dec; 140(12):5566-78. PubMed ID: 10579320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Effects of Estrogen Receptor β Isoforms on Glioblastoma Progression.
    Liu J; Sareddy GR; Zhou M; Viswanadhapalli S; Li X; Lai Z; Tekmal RR; Brenner A; Vadlamudi RK
    Cancer Res; 2018 Jun; 78(12):3176-3189. PubMed ID: 29661831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression.
    Harrington WR; Sheng S; Barnett DH; Petz LN; Katzenellenbogen JA; Katzenellenbogen BS
    Mol Cell Endocrinol; 2003 Aug; 206(1-2):13-22. PubMed ID: 12943986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor beta (ERbeta) expression in breast carcinomas is not correlated with estrogen receptor alpha (ERalpha) and prognosis: the Greek experience.
    Stefanou D; Batistatou A; Briasoulis E; Arkoumani E; Agnantis NJ
    Eur J Gynaecol Oncol; 2004; 25(4):457-61. PubMed ID: 15285303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERβ Isoforms Have Differential Clinical Significance in Breast Cancer Subtypes and Subgroups.
    Choi Y; Kim H; Pollack S
    Curr Issues Mol Biol; 2022 Apr; 44(4):1564-1586. PubMed ID: 35723365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
    Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
    Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor beta in the brain: from form to function.
    Weiser MJ; Foradori CD; Handa RJ
    Brain Res Rev; 2008 Mar; 57(2):309-20. PubMed ID: 17662459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta.
    Tee MK; Rogatsky I; Tzagarakis-Foster C; Cvoro A; An J; Christy RJ; Yamamoto KR; Leitman DC
    Mol Biol Cell; 2004 Mar; 15(3):1262-72. PubMed ID: 14699072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort.
    Elebro K; Borgquist S; Rosendahl AH; Markkula A; Simonsson M; Jirström K; Rose C; Ingvar C; Jernström H
    Clin Cancer Res; 2017 Feb; 23(3):766-777. PubMed ID: 27810901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
    Lu W; Katzenellenbogen BS
    Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of oestrogen receptor (ER)-beta and its variants, but not ERalpha, in adult human mammary fibroblasts.
    Palmieri C; Saji S; Sakaguchi H; Cheng G; Sunters A; O'Hare MJ; Warner M; Gustafsson JA; Coombes RC; Lam EW
    J Mol Endocrinol; 2004 Aug; 33(1):35-50. PubMed ID: 15291741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor beta isoforms exhibit differences in ligand-activated transcriptional activity in an estrogen response element sequence-dependent manner.
    Ramsey TL; Risinger KE; Jernigan SC; Mattingly KA; Klinge CM
    Endocrinology; 2004 Jan; 145(1):149-60. PubMed ID: 14500565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An estrogen receptor beta isoform that lacks exon 5 has dominant negative activity on both ERalpha and ERbeta.
    Inoue S; Ogawa S; Horie K; Hoshino S; Goto W; Hosoi T; Tsutsumi O; Muramatsu M; Ouchi Y
    Biochem Biophys Res Commun; 2000 Dec; 279(3):814-9. PubMed ID: 11162434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.